Skip to main content

Sheetal Hardikar receives K07

Jul 31, 2018

We are pleased to announce Sheetal Hardikar has received her 5 year NCI grant on Diabetes, Medications and the Cost-Effectiveness of Screening for Colorectal Neoplasia.

This study aims to determine the link between clinically diagnosed type-2 diabetes mellitus, use of anti-diabetic medications, and risk of colorectal polyp subtypes, including differences by lesion severity. Evaluating the cost-effectiveness of CRC screening among persons with type-2 diabetes may help inform targeted screening recommendations, which could, in turn, lower the incidence and mortality of CRC among persons with T2DM, and improve the cost-effectiveness of CRC screening.

Congratulations Dr. Hardikar!